Strong Buy
Average AnalystStrong Buy
Top AnalystSlightly Bearish
Stock Target AdvisorN/A
Average UserUSD 20.37
+1.20 (+6.26)%
USD 1.31B
0.81M
USD 30.29(+48.68%)
Stock Target Advisor calculates key financial raios, of all the stocks in our database on a daily basis and then compares and ranks the financial ratios against those of other stocks in the same industries and exchanges. This allows our users to quickly determine how a stock is performing against its peers.
Ratio vs. Industry/Classification (Health Information Services) |
Ratio vs. Market |
||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade |
---|
Financial ratios do not impart much information on their own unless they are compared against the ratios of similar stocks. Every day we run millions of calculations to determine the pertinent ratios for each stock, and then we rank the stock against the stocks in the same exchange and sector for each ratio and assign a grade based on the percentile ranking based on the table below. Stock Target Advisor’s users can quickly determine where their favourite stocks stand by looking at their grades for key ratios.
Grade | Percentile | Grade | Percentile | Grade | Percentile |
---|---|---|---|---|---|
A+ | 97%-100% | A | 93%-96% | A- | 90%-92% |
B+ | 87%-89% | B | 83%-86% | B- | 80%-82% |
C+ | 77%-79% | C | 73%-76% | C- | 70%-72% |
D+ | 67%-69% | D | 63%-66% | D- | 60%-62% |
F | 0%-59% |
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company had positive total cash flow in the most recent four quarters.
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
The stock is trading high compared to its peers median on a price to book value basis.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The company had negative total free cash flow in the most recent four quarters.